Ataxia-telangiectasia: recommendations for multidisciplinary treatment

Area of Science:

• Neurodegenerative Diseases
• Genetics and Genomics
• Immunology

Background:

• Ataxia-telangiectasia (A-T) is a rare, inherited neurodegenerative and multisystem disorder.
• Characterized by cerebellar ataxia, oculocutaneous telangiectasia, immunodeficiency, respiratory failure, and increased cancer risk.
• Distinct classic and variant phenotypes exist, necessitating tailored care.

Purpose of the Study:

• To summarize common medical problems encountered in patients with classic and variant ataxia-telangiectasia.
• To provide evidence- and expert-based recommendations for follow-up and treatment.
• To offer a practical guide for managing diverse clinical aspects of A-T.

Main Methods:

• Guideline development based on expert consensus and available evidence.
• Comprehensive review of medical problems across neurology, immunology, pulmonology, oncology, and other domains.
• Synthesis of recommendations for patient management.

Main Results:

• Identification of frequently encountered medical issues in A-T patients.
• Development of practical recommendations for managing neurological, immunological, respiratory, oncological, and other complications.
• Guidance for anesthetic and perioperative risks, endocrinology, and nutrition.

Conclusions:

• This guideline offers a comprehensive approach to managing the complex needs of ataxia-telangiectasia patients.
• It addresses both classic and variant phenotypes, promoting standardized yet individualized care.
• Provides essential information for healthcare professionals involved in A-T patient management.